Nanorobotics

Nanorobots for Targeting and Destroying Cancer Cells

Health Tech & Life Sciences
Non Active, Nov 2024 ceased to operate
Pre-Funding Hod HaSharon, Israel Founded 2019
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2019
Headcount
4
HQ
Hod HaSharon, Israel
Sector
Health Tech & Life Sciences

About

Nanorobotics is a preclinical-stage startup on a mission to eradicate cancer by harnessing the power of its breakthrough, patented light-activated nanomolecular platform technology.

Nanorobotics platforms leverage the unique characteristics of a Molecular Nanomachines (MNMs), which can drill mechanically through the cell membrane, to develop a pipeline of safe and effective molecular therapies for treating cancers that have shown resistance to conventional therapies.

Nanorobotics leading molecule, MNM96, exhibits an excellent preclinical efficacy and safety profile and is well positioned to advance toward the first human clinical trials in 2025.

Q&A

What is Nanorobotics' primary mission?
Nanorobotics is a preclinical-stage startup focused on eradicating cancer using its patented light-activated nanomolecular platform technology.
What is the current status of Nanorobotics?
Nanorobotics is currently inactive, having ceased operations in November 2024.
When was Nanorobotics founded?
Nanorobotics was founded in May 2019.
What is Nanorobotics' leading molecule?
Nanorobotics' leading molecule is MNM96, which has shown excellent preclinical efficacy and safety.
What is the employee count for Nanorobotics?
Nanorobotics has 1-10 employees.
What is the primary sector of Nanorobotics?
Nanorobotics operates within the Health Tech & Life Sciences sector.
Does Nanorobotics hold any patents?
Yes, Nanorobotics holds one patent.
Who is the CO-founder and CEO of Nanorobotics?
Yossi Keret is the CO-founder and CEO of Nanorobotics.

Team · 1

Founder · CO-founder and CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

pharmaceuticalscancer-therapyoncologytreatmentstargeted-therapybiotechnologycell-therapynanotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/65689400

Identifiers & details

Founded2019-5
Employees (exact)4
Status reasonNon Active, Nov 2024 ceased to operate